Kupffer cells in the liver.

Kupffer cells are a critical component of the mononuclear phagocytic system and are central to both the hepatic and systemic response to pathogens. Kupffer cells are reemerging as critical mediators of both liver injury and repair. Kupffer cells exhibit a tremendous plasticity; depending on the local metabolic and immune environment, then can express a range of polarized phenotypes, from the proinflammatory M1 phenotype to the alternative/M2 phenotype. Multiple M2 phenotypes can be distinguished, each involved in the resolution of inflammation and wound healing. Here, we have provided an update on recent research that has contributed to the developing delineation of the contribution of Kupffer cells to different types of liver injury, with an emphasis on alcoholic and nonalcoholic liver diseases. These recent advances in our understanding of Kupffer cell function and regulation will likely provide new insights into the potential for therapeutic manipulation of Kupffer cells to promote the resolution of inflammation and enhance wound healing in liver disease.

[1]  C. Stephens,et al.  Mechanisms of drug-induced liver injury , 2014, Current opinion in allergy and clinical immunology.

[2]  J. Iredale,et al.  Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. , 2012, Journal of hepatology.

[3]  M. Vidali,et al.  Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. , 2012, Clinical science.

[4]  Anton P. McCaffrey,et al.  Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes* , 2012, The Journal of Biological Chemistry.

[5]  T. Roskams,et al.  Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease , 2012, Nature Medicine.

[6]  L. Kazdová,et al.  Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages , 2012, Nutrition & Metabolism.

[7]  T. Luedde,et al.  Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice , 2012, Hepatology.

[8]  A. Feldstein,et al.  Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis , 2011, Laboratory Investigation.

[9]  N. Lanthier,et al.  Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Hong-Yang Wang,et al.  Nuclear factor high‐mobility group box1 mediating the activation of toll‐like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice , 2011, Hepatology.

[11]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[12]  F. Kim,et al.  Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding , 2011, Diabetes.

[13]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[14]  A. Mallat,et al.  Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice , 2011, Hepatology.

[15]  A. Feldstein,et al.  Identification of a Cytochrome P4502E1/Bid/C1q-dependent Axis Mediating Inflammation in Adipose Tissue after Chronic Ethanol Feeding to Mice* , 2011, The Journal of Biological Chemistry.

[16]  L. Nagy,et al.  Redox signaling and the innate immune system in alcoholic liver disease. , 2011, Antioxidants & redox signaling.

[17]  K. Clément,et al.  Krüppel-like factor 4 regulates macrophage polarization. , 2011, The Journal of clinical investigation.

[18]  Jonathan C. Cohen,et al.  Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.

[19]  F. Finkelman,et al.  Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation , 2011, Science.

[20]  G. Arteel,et al.  Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. , 2011, Archives of biochemistry and biophysics.

[21]  L. Nagy,et al.  Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[22]  Laura E Nagy,et al.  Obesity, diabetes mellitus, and liver fibrosis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[23]  K. Kharbanda,et al.  Ethanol feeding potentiates the pro-inflammatory response of Kupffer cells to cellular fibronectin. , 2011, Alcoholism, clinical and experimental research.

[24]  P. Mandal,et al.  Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization , 2011, The Journal of Biological Chemistry.

[25]  Manolito Torralba,et al.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.

[26]  G. Godlewski,et al.  Endocannabinoids in liver disease , 2011, Hepatology.

[27]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[28]  S. Sakaguchi,et al.  Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. , 2011, Drug metabolism and pharmacokinetics.

[29]  M. Morita,et al.  Role of tumor-associated macrophages in the progression of hepatocellular carcinoma , 2011, Surgery Today.

[30]  K. Kodys,et al.  Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease* , 2010, The Journal of Biological Chemistry.

[31]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[32]  L. Nagy,et al.  Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. , 2010, Journal of hepatology.

[33]  A. Stavitsky,et al.  Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. , 2010, Gastroenterology.

[34]  I. Leclercq,et al.  NFκB, cytokines, TLR 3 and 7 expression in human end‐stage HCV and alcoholic liver disease , 2010 .

[35]  D. Brenner,et al.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. , 2010, Gastroenterology.

[36]  L. Nagy,et al.  Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. , 2010, The American journal of pathology.

[37]  David M. Mosser,et al.  Exploring the full spectrum of macrophage activation , 2010, Nature Reviews Immunology.

[38]  P. Adegboyega,et al.  Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis , 2010, BMC gastroenterology.

[39]  G. Arteel,et al.  PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[40]  Z. Younossi,et al.  Review: Treatment options for nonalcoholic fatty liver disease , 2010, Therapeutic advances in gastroenterology.

[41]  Michael Müller,et al.  Kupffer cells promote hepatic steatosis via interleukin‐1β–dependent suppression of peroxisome proliferator‐activated receptor α activity , 2010, Hepatology.

[42]  H. Ginsberg,et al.  C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis , 2010, Diabetes.

[43]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[44]  I. Leclercq,et al.  NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease. , 2010, European journal of clinical investigation.

[45]  J. Dubé,et al.  Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance , 2009, Diabetes.

[46]  R. Pierce,et al.  Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. , 2009, Biochimica et Biophysica Acta.

[47]  L. Joosten,et al.  The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity , 2009 .

[48]  A. Keshavarzian,et al.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. , 2009, Alcoholism, clinical and experimental research.

[49]  P. Turnbaugh,et al.  The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.

[50]  R. Rao Endotoxemia and gut barrier dysfunction in alcoholic liver disease , 2009, Hepatology.

[51]  J. Lamb,et al.  The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation , 2009, Diabetes.

[52]  S. Kihara,et al.  Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[53]  Patrice D Cani,et al.  Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. , 2009, Biochemical and biophysical research communications.

[54]  G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view. , 2009, Journal of hepatology.

[55]  J. Kluwe,et al.  Toll-like receptors as targets in chronic liver diseases , 2009, Gut.

[56]  Zheng Shen,et al.  Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[57]  N. Van Rooijen,et al.  An early complement‐dependent and TLR‐4–independent phase in the pathogenesis of ethanol‐induced liver injury in mice , 2009, Hepatology.

[58]  A. Keshavarzian,et al.  Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. , 2009, Journal of hepatology.

[59]  R. Ray,et al.  Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog , 2009, Proceedings of the National Academy of Sciences.

[60]  N. Warner,et al.  Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.

[61]  Min You,et al.  Adiponectin and alcoholic fatty liver disease , 2008, IUBMB life.

[62]  A. Chawla,et al.  Mechanisms of macrophage activation in obesity-induced insulin resistance , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[63]  A. Dolganiuc,et al.  The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 , 2008, Hepatology.

[64]  V. Gordeuk,et al.  Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[65]  J. Reiser,et al.  TRIF and IRF-3 Binding to the TNF Promoter Results in Macrophage TNF Dysregulation and Steatosis Induced by Chronic Ethanol1 , 2008, The Journal of Immunology.

[66]  S. Friedman,et al.  Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.

[67]  G. Arteel New role of plasminogen activator inhibitor‐1 in alcohol‐induced liver injury , 2008, Journal of gastroenterology and hepatology.

[68]  N. Chalasani,et al.  Nonalcoholic fatty liver disease as a component of the metabolic syndrome , 2008, Current gastroenterology reports.

[69]  Dominic P. Williams,et al.  Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. , 2008, Expert opinion on drug metabolism & toxicology.

[70]  G. Arteel,et al.  Early growth response-1 contributes to galactosamine/lipopolysaccharide-induced acute liver injury in mice. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[71]  P. Adegboyega,et al.  Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.

[72]  S. Previs,et al.  Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. , 2007, Alcoholism, clinical and experimental research.

[73]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[74]  J. Fallowfield,et al.  Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1 , 2007, The Journal of Immunology.

[75]  A. Stavitsky,et al.  Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. , 2007, Gastroenterology.

[76]  C. Day,et al.  Genetics of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease , 2007, Seminars in liver disease.

[77]  P. Jares,et al.  Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. , 2007, Gastroenterology.

[78]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[79]  K. Kharbanda,et al.  Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. , 2007, Alcoholism, clinical and experimental research.

[80]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[81]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[82]  V. Thakur,et al.  Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS‐stimulated ERK1/2 activation and TNF‐α production , 2006, Journal of leukocyte biology.

[83]  D. Franchimont,et al.  Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver , 2006, Hepatology.

[84]  B. Copple,et al.  Early growth response factor-1 is critical for cholestatic liver injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[85]  L. Diehl,et al.  CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens , 2006, Cell.

[86]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[87]  S. Meri,et al.  Complement C3 contributes to ethanol‐induced liver steatosis in mice , 2006, Annals of medicine.

[88]  G. Lewison,et al.  Worldwide alcohol-related research and the disease burden. , 2006, Alcohol and alcoholism.

[89]  N. Enomoto,et al.  Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. , 2005, Alcoholism, clinical and experimental research.

[90]  Jiahuai Han,et al.  Limiting inflammatory responses during activation of innate immunity , 2005, Nature Immunology.

[91]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[92]  L. Romics,et al.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. , 2005, Alcoholism, clinical and experimental research.

[93]  L. Nagy,et al.  Ethanol-induced liver injury: potential roles for egr-1. , 2005, Alcoholism, clinical and experimental research.

[94]  K. Hunt,et al.  Synergistic enhancement of Toll‐like receptor responses by NOD1 activation , 2005, European journal of immunology.

[95]  Jörg Köhl,et al.  Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans , 2005, Nature Genetics.

[96]  K. Mak,et al.  Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[97]  C. Croniger,et al.  Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. , 2005, Gastroenterology.

[98]  L. Jacobs,et al.  Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release 1 , 2005, The Journal of Immunology.

[99]  S. Harrison,et al.  Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease , 2005, Current gastroenterology reports.

[100]  K. Fukase,et al.  Muramyldipeptide and diaminopimelic acid‐containing desmuramylpeptides in combination with chemically synthesized Toll‐like receptor agonists synergistically induced production of interleukin‐8 in a NOD2‐ and NOD1‐dependent manner, respectively, in human monocytic cells in culture , 2004, Cellular microbiology.

[101]  P. Amenta,et al.  The hepatic extracellular matrix , 1993, Virchows Archiv A.

[102]  A. Hevener,et al.  IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.

[103]  L. Klassen,et al.  Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. , 2004, Alcoholism, clinical and experimental research.

[104]  P. Gasque Complement: a unique innate immune sensor for danger signals. , 2004, Molecular immunology.

[105]  R. Taub Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[106]  J. Suttles,et al.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.

[107]  T. Morgan,et al.  Epidemiology of Alcoholic Liver Disease , 2004, Seminars in liver disease.

[108]  D. Laskin,et al.  Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. , 2003, Toxicology and applied pharmacology.

[109]  C. Sempos,et al.  Alcohol as a Risk Factor for Global Burden of Disease , 2003, European Addiction Research.

[110]  L. Nagy Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.

[111]  P. Gasque,et al.  Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  G. Núñez,et al.  Cell death and immunity: NODs: intracellular proteins involved in inflammation and apoptosis , 2003, Nature Reviews Immunology.

[113]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[114]  G. Arteel Oxidants and antioxidants in alcohol-induced liver disease. , 2003, Gastroenterology.

[115]  A. Ischenko,et al.  Complement component anaphylatoxins upregulate chemokine expression by human astrocytes , 2003, FEBS letters.

[116]  O. Götze,et al.  Expression and induction of anaphylatoxin C5a receptors in the rat liver. , 2003, Histology and histopathology.

[117]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[118]  J. Brady,et al.  Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. , 2002, Chemical research in toxicology.

[119]  T. F. Murray,et al.  The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan* , 2002, The Journal of Biological Chemistry.

[120]  G. Bagby,et al.  Sex differences in the modulation by ethanol of lung chemotaxis. , 2002, Alcohol.

[121]  J. Hoek,et al.  Ethanol, oxidative stress, and cytokine-induced liver cell injury. , 2002, Alcohol.

[122]  M. McMullen,et al.  Chronic Ethanol Increases Lipopolysaccharide-stimulated Egr-1 Expression in RAW 264.7 Macrophages , 2002, The Journal of Biological Chemistry.

[123]  J. Kolls,et al.  Alcohol, host defence and society , 2002, Nature Reviews Immunology.

[124]  O. Götze,et al.  Inhibition by prostaglandin E(2) of anaphylatoxin C5a- but not zymosan-induced prostanoid release from rat Kupffer cells. , 2002, Laboratory investigation; a journal of technical methods and pathology.

[125]  Jeanette R. Hill,et al.  ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[126]  I. Rusyn,et al.  The role of Kupffer cell oxidant production in early ethanol-induced liver disease. , 2001, Free radical biology & medicine.

[127]  M. McMullen,et al.  Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. , 2001, The Journal of biological chemistry.

[128]  M. Walport Complement. First of two parts. , 2001, The New England journal of medicine.

[129]  O. Götze,et al.  Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. , 2001, International immunopharmacology.

[130]  J. Kolls,et al.  Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. , 2001, Alcoholism, clinical and experimental research.

[131]  H. Tsukamoto,et al.  Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. , 2001, American journal of physiology. Endocrinology and metabolism.

[132]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[133]  A. Keshavarzian,et al.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats , 2000, Hepatology.

[134]  S. Targan,et al.  Tumor necrosis factor: biology and therapeutic inhibitors. , 2000, Gastroenterology.

[135]  I. Rusyn,et al.  NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. , 2000, The Journal of clinical investigation.

[136]  C. McClain,et al.  Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. , 2000, The Journal of laboratory and clinical medicine.

[137]  T. Mayadas,et al.  Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. , 2000, Immunopharmacology.

[138]  G. Szabo Consequences of alcohol consumption on host defence. , 1999, Alcohol and alcoholism.

[139]  N. Pumford,et al.  Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species , 1999, Hepatology.

[140]  S. Maier,et al.  Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. , 1999, Life sciences.

[141]  D. Broide,et al.  A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. , 1999, Journal of immunology.

[142]  L. Nagy,et al.  Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF-alpha production in rat Kupffer cells. , 1999, The American journal of physiology.

[143]  Z. Younossi EPIDEMIOLOGY OF ALCOHOL-INDUCED LIVER DISEASE , 1998 .

[144]  R. Thurman,et al.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[145]  Z. Spolarics,et al.  Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid , 1998, Journal of leukocyte biology.

[146]  Makoto Naito,et al.  Development, differentiation, and maturation of Kupffer cells , 1998, Microscopy research and technique.

[147]  B. Beutler TNF, immunity and inflammatory disease: lessons of the past decade. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[148]  Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen , 1995, Hepatology.

[149]  A. Gressner,et al.  Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells. , 1995, Digestion.

[150]  H. K. Bojes,et al.  Inactivation of Kupffer cells prevents early alcohol‐induced liver injury , 1994, Hepatology.

[151]  R. Raghow,et al.  The role of extracellular matrix in postinflammatory wound healing and fibrosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[152]  A. Nanji,et al.  Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. , 1993, The American journal of pathology.

[153]  C. McClain,et al.  Tumor necrosis factor in alcohol enhanced endotoxin liver injury. , 1992, Alcoholism, clinical and experimental research.

[154]  C. Jacob Tumor necrosis factor α in autoimmunity: pretty girl or old witch? , 1992 .

[155]  C. Jacob Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? , 1992, Immunology today.

[156]  C. Bode,et al.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.

[157]  A. Khoruts,et al.  Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients , 1991, Hepatology.

[158]  M. Kazatchkine,et al.  Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[159]  C. McClain,et al.  Increased tumor necrosis factor production by monocytes in alcoholic hepatitis , 1989, Hepatology.

[160]  C. Bode,et al.  Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. , 1987, Journal of hepatology.